This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a delivery order for the supply of Quillivant XR 25 mg/5 ml suspension medication. It is a firm fixed-price contract with a period of performance ending on December 27, 2024. The contract is not designated as a set-aside.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely a call under that broader IDC mechanism.
Generated 3/27/25, 9:59 AM